603233 logo

DaShenLin Pharmaceutical Group Co., Ltd. Stock Price

SHSE:603233 Community·CN¥20.8b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 1 Fair Values set on narratives written by author

603233 Share Price Performance

CN¥18.25
3.76 (25.95%)
CN¥18.25
3.76 (25.95%)
Price CN¥18.25

603233 Community Narratives

There are no narratives available yet.

Snowflake Analysis

Undervalued with solid track record and pays a dividend.

1 Risk
4 Rewards

DaShenLin Pharmaceutical Group Co., Ltd. Key Details

CN¥26.8b

Revenue

CN¥17.6b

Cost of Revenue

CN¥9.2b

Gross Profit

CN¥8.1b

Other Expenses

CN¥1.1b

Earnings

Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
n/a
1.00
34.36%
4.24%
42.9%
View Full Analysis

About 603233

Founded
1999
Employees
43532
CEO
Guoqiang Ke
WebsiteView website
www.dslyy.com

DaShenLin Pharmaceutical Group Co., Ltd. manufactures, distributes, and retails pharmaceutical products in China. It provides Chinese and Western patent medicines, ginseng and antler tonic medicinal materials, Chinese herbal medicine slices, health products, medical devices, and other commodities. The company was incorporated in 1999 and is based in Guangzhou, China.

Recent 603233 News & Updates

Recent updates

No updates